Aarti Pharmalabs Limited

₹929.70As of Sun 8 Nov 2026, 12:00 UTC
NSE:AARTIPHARMHealthcare
Country India
PE (Fwd) •••
TSR 4Y CAGR 38.89%
Div yield 0.38%
ROE 8.49%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM 41.21
TSR TTM 9.62%
Mkt cap ₹84.31B
ROIC 8.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,089
17.16%
(81.76%)
Hold 2|0|8|12|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
15.26
16.81
18.62
20.64
19.64%
29.47%
33.23%
49.27%
Revenue₹B
8.838
8.576
8.442
8.194
9.81%
6.22%
0.68%
(2.55%)
Peers (US$898.1M)
Cap (US$)
PE
980.8M
24.30x
Capital
TTM
5Y
10Y
Leveragex
0.370
0.180
0.112
EBIT/Intx
0.821
0.129
0.129
Own earn%
35.89
76.99
85.78
Sh yield%
27.24
18.83
17.50
Owners
Insiders/Inst%
1.12
32.50
Short interest%
3.93
SBC / revenue%
0.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
14–19
$1 testx
−0.7
Incr. ROIC%
3